Literature DB >> 22909391

A model for the relative biological effectiveness of protons: the tissue specific parameter α/β of photons is a predictor for the sensitivity to LET changes.

Minna Wedenberg1, Bengt K Lind, Björn Hårdemark.   

Abstract

BACKGROUND: The biological effects of particles are often expressed in relation to that of photons through the concept of relative biological effectiveness, RBE. In proton radiotherapy, a constant RBE of 1.1 is usually assumed. However, there is experimental evidence that RBE depends on various factors. The aim of this study is to develop a model to predict the RBE based on linear energy transfer (LET), dose, and the tissue specific parameter α/β of the linear-quadratic model for the reference radiation. Moreover, the model should capture the basic features of the RBE using a minimum of assumptions, each supported by experimental data.
MATERIAL AND METHODS: The α and β parameters for protons were studied with respect to their dependence on LET. An RBE model was proposed where the dependence of LET is affected by the (α/β)phot ratio of photons. Published cell survival data with a range of well-defined LETs and cell types were selected for model evaluation rendering a total of 10 cell lines and 24 RBE values. RESULTS AND
CONCLUSION: A statistically significant relation was found between α for protons and LET. Moreover, the strength of that relation varied significantly with (α/β)phot. In contrast, no significant relation between β and LET was found. On the whole, the resulting RBE model provided a significantly improved fit (p-value < 0.01) to the experimental data compared to the standard constant RBE. By accounting for the α/β ratio of photons, clearer trends between RBE and LET of protons were found, and our results suggest that late responding tissues are more sensitive to LET changes than early responding tissues and most tumors. An advantage with the proposed RBE model in optimization and evaluation of treatment plans is that it only requires dose, LET, and (α/β)phot as input parameters. Hence, no proton specific biological parameters are needed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22909391     DOI: 10.3109/0284186X.2012.705892

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  44 in total

Review 1.  Robust Proton Treatment Planning: Physical and Biological Optimization.

Authors:  Jan Unkelbach; Harald Paganetti
Journal:  Semin Radiat Oncol       Date:  2018-04       Impact factor: 5.934

Review 2.  Proton relative biological effectiveness (RBE): a multiscale problem.

Authors:  Tracy Sa Underwood; Stephen J McMahon
Journal:  Br J Radiol       Date:  2018-07-26       Impact factor: 3.039

3.  Extension of TOPAS for the simulation of proton radiation effects considering molecular and cellular endpoints.

Authors:  Lisa Polster; Jan Schuemann; Ilaria Rinaldi; Lucas Burigo; Aimee L McNamara; Robert D Stewart; Andrea Attili; David J Carlson; Tatsuhiko Sato; José Ramos Méndez; Bruce Faddegon; Joseph Perl; Harald Paganetti
Journal:  Phys Med Biol       Date:  2015-06-10       Impact factor: 3.609

4.  Using the Proton Energy Spectrum and Microdosimetry to Model Proton Relative Biological Effectiveness.

Authors:  Mark Newpower; Darshana Patel; Lawrence Bronk; Fada Guan; Pankaj Chaudhary; Stephen J McMahon; Kevin M Prise; Giuseppe Schettino; David R Grosshans; Radhe Mohan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-02-05       Impact factor: 7.038

Review 5.  Radiobiological issues in proton therapy.

Authors:  Radhe Mohan; Christopher R Peeler; Fada Guan; Lawrence Bronk; Wenhua Cao; David R Grosshans
Journal:  Acta Oncol       Date:  2017-08-22       Impact factor: 4.089

Review 6.  Modelling variable proton relative biological effectiveness for treatment planning.

Authors:  Aimee McNamara; Henning Willers; Harald Paganetti
Journal:  Br J Radiol       Date:  2019-11-18       Impact factor: 3.039

7.  A new formalism for modelling parameters α and β of the linear-quadratic model of cell survival for hadron therapy.

Authors:  Oleg N Vassiliev; David R Grosshans; Radhe Mohan
Journal:  Phys Med Biol       Date:  2017-10-03       Impact factor: 3.609

8.  Linear energy transfer-guided optimization in intensity modulated proton therapy: feasibility study and clinical potential.

Authors:  Drosoula Giantsoudi; Clemens Grassberger; David Craft; Andrzej Niemierko; Alexei Trofimov; Harald Paganetti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-06-19       Impact factor: 7.038

9.  Reoptimization of Intensity Modulated Proton Therapy Plans Based on Linear Energy Transfer.

Authors:  Jan Unkelbach; Pablo Botas; Drosoula Giantsoudi; Bram L Gorissen; Harald Paganetti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-09-01       Impact factor: 7.038

10.  Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma.

Authors:  Christopher R Peeler; Dragan Mirkovic; Uwe Titt; Pierre Blanchard; Jillian R Gunther; Anita Mahajan; Radhe Mohan; David R Grosshans
Journal:  Radiother Oncol       Date:  2016-11-16       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.